Published by Alexander Bueso on 28th November 2022
(Sharecast News) - Analysts at Liberum cut their target price for shares Oxford Biomedica arguing that the company's pan-vector offering had yet to reach sufficient scale in order to deliver sustainable profitability.
URL: http://www.digitallook.com/dl/news/story/33137622/...